The National Institutes of Health estimated overall costs for cancer in 2006 at $206 billion. For years, oncologists have been the gatekeepers for many costly oncology drugs, purchasing injectable drugs from a small group of oncology drug distributors for administration in their office. Oncology drugs are estimated to represent as much as 40 percent of the specialty drug spend today, approximately $20 to $25 billion according to market estimates. For most health plans, oncology represents more than 50% of payer costs for pharmaceuticals administered in a physician-office setting. Knowledge Source's Oncology Purchasing & Distribution Market Overview provides the information and analysis you need to gain an understanding of the trends impacting oncology purchasing and distribution. Knowledge Source's Oncology Purchasing & Distribution Groups Market Overview, 115 pages, also identifies twenty of the major market participants and provides brief profiles which include (when available): Company Background, Corporate Strategy, Products and Services, and Recent Activities. | 
Scroll to this section
Healthcare Market Overviews